Version May 2024
| Drug (abbreviations) | Brand name in the United States |
| Nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) | |
| Abacavir (ABC) | Ziagen |
| Emtricitabine (FTC) | Emtriva |
| Lamivudine (3TC) | Epivir |
| Stavudine (d4T) | Zerit¶ |
| Tenofovir alafenamide (TAF) | Vemlidy |
| Tenofovir disoproxil fumarate (TDF) | Viread |
| Zidovudine (ZDV, AZT) | Retrovir |
| Non-nucleoside reverse transcriptase inhibitors (NNRTIs) | |
| Doravirine (DOR) | Pifeltro |
| Efavirenz (EFV) | Sustiva |
| Etravirine (ETR) | Intelence |
| Nevirapine (NVP) | Viramune, Viramune XR¶ |
| Rilpivirine (RPV) | Edurant |
| Protease inhibitors (PIs) | |
| Atazanavir (ATV) | Reyataz |
| Atazanavir-cobicistat (ATV/COBI) | Evotaz |
| Darunavir (DRV) | Prezista |
| Darunavir-cobicistat (DRV/COBI) | Prezcobix |
| Fosamprenavir (FPV) | Lexiva |
| Lopinavir/ritonavir boosting (LPV/r) | Kaletra |
| Nelfinavir (NFV) | Viracept |
| Ritonavir (RTV) (used as a pharmacokinetic boosting agent) | Norvir |
| Tipranavir (TPV) | Aptivus |
| Fusion inhibitor | |
| Enfuvirtide (T-20) | Fuzeon |
| Integrase strand transfer inhibitors (INSTIs)* | |
| Cabotegravir (CAB; oral formulation) | Vocabria |
| Dolutegravir (DTG) | Tivicay, Tivicay PD |
| Raltegravir (RAL) | Isentress, Isentress HD |
| CCR5 antagonist | |
| Maraviroc (MVC) | Selzentry |
| Attachment inhibitor | |
| Fostemsavir | Rukobia |
| Post-attachment inhibitor | |
| Ibalizumab (IBA) | Trogarzo |
| Capsid inhibitor | |
| Lenacapavir (LEN) | Sunlenca |
| Fixed-dose oral combinations | |
| Abacavir-lamivudine (ABC/3TC) | Epzicom |
| Abacavir-lamivudine-zidovudine (ABC/3TC/ZDV) | Trizivir |
| Bictegravir-emtricitabine-tenofovir alafenamide (BIC/FTC/TAF) | Biktarvy |
| Darunavir-cobicistat-emtricitabine-tenofovir alafenamide (DRV/COBI/FTC/TAF) | Symtuza |
| Dolutegravir-abacavir-lamivudine (DTG/ABC/3TC) | Triumeq, Triumeq PD |
| Dolutegravir-lamivudine (DTG/3TC) | Dovato |
| Dolutegravir-rilpivirine (DTG/RPV) | Juluca |
| Doravirine-lamivudine-tenofovir disoproxil fumarate (DOR/3TC/TDF) | Delstrigo |
| Efavirenz-emtricitabine-tenofovir disoproxil fumarate (EFV/FTC/TDF) | Atripla¶ |
| Efavirenz-lamivudine-tenofovir disoproxil fumarate (EFV/3TC/TDF) | Symfi, Symfi Lo |
| Elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide (ECF/TAF or EVG/COBI/FTC/TAF) | Genvoya |
| Elvitegravir-cobicistat-emtricitabine-tenofovir disoproxil fumarate (ECF/TDF or EVG/COBI/FTC/TDF) | Stribild |
| Lamivudine-tenofovir disoproxil fumarate (3TC/TDF) | Cimduo |
| Rilpivirine-emtricitabine-tenofovir alafenamide (RPV/FTC/TAF) | Odefsey |
| Rilpivirine-emtricitabine-tenofovir disoproxil fumarate (RPV/FTC/TDF) | Complera |
| Tenofovir alafenamide-emtricitabine (TAF/FTC) | Descovy |
| Tenofovir disoproxil fumarate-emtricitabine (TDF/FTC) | Truvada |
| Zidovudine-lamivudine (ZDV/3TC) | Combivir |
| Injectable combination | |
| Cabotegravir-rilpivirine (CAB/RPV; extended-release injectable formulation) | Cabenuva |
* Some agents (eg, bictegravir, elvitegravir) are only available in fixed dose combinations and are listed in that category and not within their mechanistic class.
¶ Only available generically.آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟
